Marc Funk is CEO of Recipharm, a top 5 global CDMO of active pharmaceutical ingredients (APIs), advanced therapies, and drug products. Marc specializes in strategic transformations and international negotiations, and in his current role, he combines his passion for innovation and entrepreneurial mindset to drive growth and success for one of the largest global pharma and biotech CDMO players. Before Recipharm, he took the same approach in transforming the pharma and biotech CDMO business at Lonza Group.
Contract development and manufacturing organizations cannot develop or distribute vaccines alone, but through partnerships, their infrastructure can provide the foundation for delivering life-saving tools swiftly and equitably when a new public health crisis emerges.